Luo, S., Hieu, T. B., Ma, F., Yu, Y., Cao, Z., Wang, M., . . . Zhu, Y. Z. (2017). ZYZ-168 alleviates cardiac fibrosis after myocardial infarction through inhibition of ERK1/2-dependent ROCK1 activation. Nature Publishing Group.
Chicago Style (17th ed.) CitationLuo, Shanshan, et al. ZYZ-168 Alleviates Cardiac Fibrosis After Myocardial Infarction Through Inhibition of ERK1/2-dependent ROCK1 Activation. Nature Publishing Group, 2017.
MLA (9th ed.) CitationLuo, Shanshan, et al. ZYZ-168 Alleviates Cardiac Fibrosis After Myocardial Infarction Through Inhibition of ERK1/2-dependent ROCK1 Activation. Nature Publishing Group, 2017.
Warning: These citations may not always be 100% accurate.